Publikace
- The interaction between the anticancer drug ellipticine and cytochromes P450 dictates its pharmacological efficiencies2003 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- Interaction of anticancer drug elliptcine with cytochromes P450 dictates its physiological properties2002 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- Anticancer drug ellipticine forms DNA adducts in vivo; A novel mode of its antineoplatic action2004 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N-2-oxide2004 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- ANTICANCER DRUG ELLIPTICINE ACTS AS AN INDUCER OF CYTOCHROMES P450 1A1/2 AND POTENTIATES ITS OWN PHARMACOLOGICAL EFFICIENCY2003 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- The anticancer drug ellipticine acts as an inducer of cytochromes P450 1A1/2 and potentiates its own pharmacological efficiency2003 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- The explanation of the inhibition effect of ellipticine on cytochromes P4502003 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- Study of ellipticine potential to induce cytochromes P4502003 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- Induction of cytochromes P450 1A1/2 by the anticancer drug ellipticine2003 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P-postlabeling2003 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
Loading network view...